Digestives & Intestinal Remedies - Mexico

Mexico

Highlights

In Mexico, the Digestives & Intestinal Remedies market market generated a revenue of MXN US$438.20m in 2024.
It is projected to experience an annual growth rate of 1.60% (CAGR 2024-2029).
When compared to other countries worldwide, China leads the market with a revenue of MXN US$4.41bn in 2024.
In terms of per capita income, Mexico's Digestives & Intestinal Remedies market market generated MXN US$3.39 per person in 2024.
In Mexico, there is a growing trend towards natural digestive remedies, as consumers seek alternative and holistic approaches to managing digestive issues.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Digestives & Intestinal Remedies market in Mexico has been experiencing significant growth in recent years.

Customer preferences: Mexican consumers are increasingly concerned about their digestive health and are seeking products that can provide relief from digestive issues such as indigestion, bloating, and constipation. They are also becoming more aware of the importance of maintaining a healthy gut microbiome and are looking for products that can support gut health. As a result, there is a growing demand for digestive and intestinal remedies in the Mexican market.

Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in Mexico is the increasing popularity of natural and herbal remedies. Consumers are gravitating towards products that are made from natural ingredients and do not contain any artificial additives or preservatives. This trend is driven by a desire for more holistic and sustainable approaches to healthcare. Manufacturers are responding to this trend by launching new products that are formulated with natural ingredients and promoting the benefits of these ingredients in their marketing campaigns.Another trend in the market is the rise of e-commerce. With the increasing penetration of internet and smartphones in Mexico, consumers are increasingly turning to online platforms to purchase Digestives & Intestinal Remedies. This trend is driven by the convenience and ease of online shopping, as well as the availability of a wide range of products and competitive prices. Manufacturers and retailers are investing in their online presence and partnering with e-commerce platforms to reach a larger customer base.

Local special circumstances: Mexico has a large population of people who suffer from digestive issues such as irritable bowel syndrome (IBS) and acid reflux. This has created a significant market opportunity for Digestives & Intestinal Remedies in the country. Additionally, the Mexican diet, which is rich in spicy and fried foods, can contribute to digestive problems. As a result, there is a high demand for products that can provide relief from these issues.

Underlying macroeconomic factors: The growing middle class in Mexico has led to an increase in disposable income and purchasing power. This has allowed more consumers to afford Digestives & Intestinal Remedies and has contributed to the growth of the market. Additionally, the aging population in Mexico is driving the demand for digestive health products, as older adults are more prone to digestive issues. The increasing urbanization and hectic lifestyles in Mexico have also contributed to the rise in digestive problems, creating a need for remedies in the market.In conclusion, the Digestives & Intestinal Remedies market in Mexico is experiencing growth due to increasing consumer preferences for natural and herbal remedies, the rise of e-commerce, the prevalence of digestive issues in the population, and underlying macroeconomic factors such as the growing middle class and aging population. Manufacturers and retailers in the market are capitalizing on these trends and special circumstances to meet the growing demand for Digestives & Intestinal Remedies in Mexico.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.